Market Overview

Nanosphere Wins FDA Clearance to Market CYP2C19 Mutations Detection Test

Related NSPH
Morning Market Losers
Midday Gainers From October 13 - Doral Financial, Nanosphere, Ibio, Atlas Energy

Nanosphere, Inc. (Nasdaq: NSPH) announced today the US FDA granted 510(k) clearance permitting marketing of its CYP2C19 Nucleic Acid Test (CYP2C19 Test) on the automated sample-to-result Verigene^® System.

Posted-In: News FDA

 

Related Articles (NSPH)

Around the Web, We're Loving...

Get Benzinga's Newsletters